Clinical Trial Update: Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the effect of rimonabant on weight gain and body composition in adults with Prader-Willi syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Rimonabant (rimonabant)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prader-willi Syndrome | Phase 3 | Status: TERMINATED